Department of Radiology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
J Xray Sci Technol. 2018;26(6):1029-1037. doi: 10.3233/XST-180430.
To explore the clinical efficacy and safety of percutaneous transvenous retrieval of intravascular fractured catheter and to evaluate the possible reasons and final results in cancer patients.
A dataset of 19 patients was used. Percutaneous transvenous retrieval of intravascular fractured catheter was performed in each patients. Clinical data was retrospectively analyzed with respect to the efficacy, safety and outcome, and chest radiography was performed to verify that no catheter fragments were left.
Two cases had peripherally inserted central catheter and 17 had subcutaneous implanted port catheter. The catheter fragments were located in the brachiocephalic vein-superior vena cava (n = 1), superior vena cava (n = 1), superior and inferior vena cava (n = 1), superior vena cava-right atrium (n = 2), brachiocephalic vein-superior vena cava-right atrium (n = 1), superior vena cava-right atrium-right ventricle (n = 6), brachiocephalic vein-superior vena cava-right atrium and right ventricle (n = 1) and pulmonary artery (n = 6), respectively. All of these catheter fragments were retrieved successfully. No complications such as bleeding and thrombosis were found.
Percutaneous transvenous retrieval is a safe, minimally invasive and relatively simple procedure for the patients with fractured catheter and should be recommended as the first choice.
探讨经皮静脉内取出血管内断裂导管的临床疗效和安全性,并评估癌症患者中可能的原因和最终结果。
使用了 19 例患者的数据。对每位患者均进行经皮静脉内取出血管内断裂导管。回顾性分析了临床资料,包括疗效、安全性和结果,并进行了胸部 X 线检查以验证是否有导管碎片残留。
2 例为外周中心静脉导管,17 例为皮下植入式端口导管。导管碎片位于头臂静脉-上腔静脉(n=1)、上腔静脉(n=1)、上腔静脉和下腔静脉(n=1)、上腔静脉-右心房(n=2)、头臂静脉-上腔静脉-右心房(n=1)、上腔静脉-右心房-右心室(n=6)、头臂静脉-上腔静脉-右心房和右心室(n=1)和肺动脉(n=6)。所有这些导管碎片均成功取出。未发现出血和血栓形成等并发症。
经皮静脉内取出血管内断裂导管是一种安全、微创且相对简单的方法,应作为首选。